Cutler Group’s Myovant Sciences Ltd. MYOV Stock Holding History

Cutler Group’s Portfolio MYOV Stock Details MYOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-5,359	Closed	-$144K	–	5065
2022 Q4	$144K	Buy	5,359 +2,257	+73%	+$59.4K	0.01%	967
2022 Q3	$55K	Buy	3,102 +1,229	+66%	+$19.6K	﹤0.01%	1829
2022 Q2	$23K	Sell	1,873 -4,502	-71%	-$49.7K	﹤0.01%	2577
2022 Q1	$84K	Buy	+6,375	New	+$85.5K	﹤0.01%	1830
2021 Q4	–	Sell	-100	Closed	-$2K	–	6419
2021 Q3	$2K	Sell	100 -300	-75%	-$6.59K	﹤0.01%	5172
2021 Q2	$9K	Buy	+400	New	+$8.42K	﹤0.01%	4036
2021 Q1	–	Sell	-2,344	Closed	-$53.4K	–	6537
2020 Q4	$64K	Sell	2,344 -1,500	-39%	-$29.2K	﹤0.01%	1825
2020 Q3	$54K	Buy	+3,844	New	+$71.5K	﹤0.01%	1757
2020 Q2	–	Sell	-300	Closed	-$4.08K	–	5076
2020 Q1	$2K	Buy	+300	New	+$3.36K	﹤0.01%	3597

Other funds holding MYOV

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Cutler Group's MYOV Position: Q1 2023 in Review

Cutler Group sold out of Myovant Sciences Ltd. (MYOV) in Q1 2023, closing a stake of 5,359 shares — an estimated $144K sold.

Cutler Group first reported a position in MYOV in Q1 2020 and held it in 9 quarters. The position peaked at $144K in Q4 2022. 2 funds tracked by Wall St. Rank hold MYOV as of Q1 2023.

Cutler Group reported no remaining Myovant Sciences Ltd. position as of Q1 2023 after selling out during the quarter.
Cutler Group sold 5,359 Myovant Sciences Ltd. shares in Q1 2023, an estimated $144K.
Cutler Group first reported a position in Myovant Sciences Ltd. in Q1 2020 and held it in 9 quarters.
Cutler Group's Myovant Sciences Ltd. position peaked at $144K in Q4 2022.
2 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q1 2023.

Based on Cutler Group's 13F filing for Q1 2023, filed 1 May 2023.